10 Novel 1,5-Diphenylpyrazole Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors with Enhanced Activity versus the Delavirdine-Resistant P236L Mutant: Lead Identification and SAR of 3- and 4-Substituted Derivatives

11 Clinical, microbiologic, and immunologic determinants of mortality in hospitalized patients with HIV-associated tuberculosis: A prospective cohort study.

12 What are mass media interventions made of? Exploring the active content of interventions designed to increase HIV testing in gay men within a systematic review.

13 Management of amphotericin-induced phlebitis among HIV patients with cryptococcal meningitis in a resource-limited setting: a prospective cohort study.

14 Feasibility of community-based HIV self-screening in South Africa: a demonstration project.

15 Fungal Opportunistic Pneumonias in HIV/AIDS Patients: An Indian Tertiary Care Experience.

16 Performance analysis of MySQL partition, hive partition-bucketing and Apache Pig

17 Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.

18 Molecular Docking Study of Four Chromene Derivatives as Novel HIV-1 Integrase Inhibitors

19 Histoplasmosis, An Underdiagnosed Disease Affecting People Living with HIV/AIDS in Brazil: Results of a Multicenter Prospective Cohort Study Using Both Classical Mycology Tests and Histoplasma Urine Antigen Detection

20 Recent advances in managing HIV-associated cryptococcal meningitis [version 1; peer review: 2 approved]

21 Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project

22 The performance of serum cryptococcal capsular polysaccharide antigen test, histopathology and culture of the lung tissue for diagnosis of pulmonary cryptococosis in patients without HIV infection

23 Characteristics of HBV infection in 705 HIV-infected patients under lamivudine-based antiretroviral treatment from three regions in China

24 Recurrent tuberculosis among HIV-coinfected patients: a case series from KwaZulu-Natal

25 High rate of HIV-1 drug resistance in treatment failure patients in Taiwan, 2009–2014

26 Clinical effectiveness of dolutegravir in the treatment of HIV/AIDS

27 The role of dolutegravir in the management of HIV infections

28 Long-term efficacy and safety of raltegravir in the management of HIV infection

29 Patterns of resistance development with integrase inhibitors in HIV

30 Extended use of raltegravir in the treatment of HIV-1 infection: optimizing therapy

31 Methicillin-resistant Staphylococcus aureus in HIV-infected patients

32 Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection

33 Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project

34 Factors Associated with Anemia among People Living with HIV/AIDS Taking ART in Ethiopia

35 Knowledge, Attitude, and Practice of Postexposure Prophylaxis against HIV Infection among Healthcare Workers in Hiwot Fana Specialized University Hospital, Eastern Ethiopia

36 Primary HIV Drug Resistance among Recently Infected Cases of HIV in North-West India

37 Consistent Condom Use and Associated Factors among HIV-Positive Clients on Antiretroviral Therapy in North West Ethiopian Health Center, 2016 GC

38 Healthcare Workers’ Perspectives on the Barriers to Providing HIV Services to Children in Sub-Saharan Africa

39 Delayed Antiretroviral Therapy (ART) Initiation among Hospitalized Adults in a Resource-Limited Settings: A Challenge to the Global Target of ART for 90 of HIV-Infected Individuals

40 The Incremental Cost of Delivering PrEP as a Bridge to ART for HIV Serodiscordant Couples in Public HIV Care Clinics in Kenya

41 Cryptococcal Meningitis in a HIV Seronegative Patient: A Rare Complication of Cerebrospinal Fluid Leak Detected with a New Cisternographic Technique

42 The performance of serum cryptococcal capsular polysaccharide antigen test, histopathology and culture of the lung tissue for diagnosis of pulmonary cryptococosis in patients without HIV infection

43 Characteristics of HBV infection in 705 HIV-infected patients under lamivudine-based antiretroviral treatment from three regions in China

44 Recurrent tuberculosis among HIV-coinfected patients: a case series from KwaZulu-Natal

45 Depression among Adult HIV/AIDS Patients Attending ART Clinics at Aksum Town, Aksum, Ethiopia: A Cross-Sectional Study

46 High rate of HIV-1 drug resistance in treatment failure patients in Taiwan, 2009–2014

47 Clinical effectiveness of dolutegravir in the treatment of HIV/AIDS

48 The role of dolutegravir in the management of HIV infections

49 Long-term efficacy and safety of raltegravir in the management of HIV infection

50 Patterns of resistance development with integrase inhibitors in HIV

51 Extended use of raltegravir in the treatment of HIV-1 infection: optimizing therapy

52 Methicillin-resistant Staphylococcus aureus in HIV-infected patients

53 Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection

54 The Lipodystrophy Syndrome in HIV-Infected Children under Antiretroviral Therapy: A First Report from the Central Africa

55 Integration of HIV-Sexual Reproductive Health Services for Young People and the Barriers at Public Health Facilities in Mbarara Municipality, Southwestern Uganda: A Qualitative Assessment

56 Longitudinal brain atrophy patterns and neuropsychological performance in older adults with HIV-associated neurocognitive disorder compared with early Alzheimer's disease.

57 Adverse childhood experiences, mental health, substance use, and HIV-related outcomes among persons with HIV

58 Barriers and facilitators to participation of men who have sex with men and transgender women in HIV research in Jamaica.

59 Tobacco Smoking, Substance Use, and Mental Health Symptoms in People with HIV in an Urban HIV Clinic.

60 Clinical correlates of depression chronicity among people living with HIV: What is the role of suicidal ideation?

61 The global magnitude of metabolic syndrome among antiretroviral therapy (ART) exposed and ART-naïve adult HIV-infected patients in gedio-zone, southern Ethiopia: Comparative cross-sectional study, using the Adult Treatment Panel III criteria.

62 Investigating the distribution of HIV-1 Tat lengths present in the Drexel Medicine CARES cohort.

63 "This conflict has turned me into a Doctor, Nurse and Nutritionist at the same time": How peer support among HIV-positive IDPs created opportunities for care in conflict-stricken Kabaré, Congo DR

64 Effects of Highly Active Antiretroviral Therapy on Albuminuria in HIV-infected Persons.

65 Gastrointestinal Parasitic Infections and Immunological Status of HIV/AIDS Coinfected Individuals in Nigeria.

66 Teledrama and HIV/AIDS Awareness in Nigeria: A Critique of Zuciyar Zinariya, on TV Taraba

67 Structural and binding insights into HIV-1 protease and P2-ligand interactions through molecular dynamics simulations, binding free energy and principal component analysis.

68 [Factors related to oral candidiasis in HIV children and adolescents, species characterization and antifungal susceptibility].

69 On the periphery of HIV and AIDS: Reflections on stress as experienced by caregivers in a child residential care facility in South Africa.

70 Knowledge, attitudes, and practices regarding antiretroviral management, reproductive health, sexually transmitted infections, and sexual risk behavior among perinatally HIV-infected youth in Thailand.

71 Factors influencing uptake of HIV care and treatment among children in South Africa - a qualitative study of caregivers and clinic staff.

72 A case of historical adaptation in Iranian media: Shahrzad as a palimpsestuous hive of intertextuality

73 The global spread of HIV-1 subtype B epidemic.

74 Travel, migration and HIV.

75 Verifying the impact of corporate governance on hospital performance on HIV and malaria control: A structural equation modelling approach.

76 Malaria care-seeking behaviour among HIV-infected patients receiving antiretroviral treatment in South-Eastern Nigeria: A cross-sectional study.

77 Prevalence of malaria parasitaemia in adult HIV-infected patients in Jos, North-central Nigeria.

78 HIV–malaria coinfection: Anti-malaria therapy in people living with HIV/AIDS in Owerri, Nigeria

79 Acceptability of HIV self-testing in African students: a cross-sectional survey in the Democratic Republic of Congo.

80 Comorbidity and polypharmacy among women living with HIV in British Columbia.

81 Avaliação da autoestima em pessoas vivendo com HIV/aids no município de Ribeirão Preto-SP

82 The effectiveness of acceptance and commitment therapy on death anxiety and mental health in women with hiv in abadan city, iran

83 Securitizing HIV/AIDS: a game changer in state-societal relations in China?

84 Scaling-up the Systems Analysis and Improvement Approach for prevention of mother-to-child HIV transmission in Mozambique (SAIA-SCALE): a stepped-wedge cluster randomized trial.

85 Reducing the African American HIV Disease Burden in the Deep South: Addressing the Role of Faith and Spirituality.

86 Cancer, chemotherapy, and HIV: Living with cancer amidst comorbidity in a South African township.

87 Renal manifestations of HIV during the antiretroviral era in South Africa: a systematic scoping review

88 D-dimer as a Predictor of Altered Coagulation in HIV Patients in Nigeria.

89 Progress toward HIV epidemic control in lesotho: results from a population-based survey.

90 Non-AIDS comorbidity burden differs by sex, race, and insurance type in aging adults in HIV care.

91 Point-of-care viral load monitoring: outcomes from a decentralized HIV programme in Malawi.

92 Multisystem impairment in South African adolescents with Perinatally acquired HIV on antiretroviral therapy (ART).

93 Incidence and Risk Factors for Renal Disease in an Outpatient Cohort of HIV-Infected Patients on Antiretroviral Therapy.

94 Increased Plasma Levels of the TH2 chemokine CCL18 associated with low CD4+ T cell counts in HIV-1-infected Patients with a Suppressed Viral Load

95 Feasibility of using dried blood spots for HIV viral load testing among HIV-infected individuals in Thailand using QIAGEN QIAsymphony-artus HIV-1 platform

96 Impact of HIV-Status Disclosure on HIV Viral Load in Pregnant and Postpartum Women on Antiretroviral Therapy

97 Evaluating the effectiveness of the HIV adolescent package of care (APOC) training on viral load suppression in Kenya

98 HIV stigma and viral load among African-American women receiving treatment for HIV

99 Control of the HIV-1 Load Varies by Viral Subtype in a Large Cohort of African Adults with Incident HIV-1 Infection

100 Analytical treatment interruption in chronic HIV-1 infection: Time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study)

101 Brief Report: Durability of the Effect of Financial Incentives on HIV Viral Load Suppression and Continuity in Care: HPTN 065 Study

Keyword Connections

Journals

Research Groups

Bibliographies